Several studies correlate Aβ-induced cognitive impairments with GSK-3β phosphorylation of tau protein residues resulting in cytoskeletal disorganization, synaptic loss and axonal disruption [8], [10]. The gene discussed is MAPT; the disease is Cognitive impairment.